Public-registry trials using ALG-055009 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| ALG-055009 in Non-cirrhotic Adults With MASH (HERALD) | Aligos Therapeutics | NASH | PHASE2 | 40 |
| First registered study | October 2021 — NCT05090111 (Aligos Therapeutics) |
| Registered studies matching this name | 4 all-time · 0 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Trialed alongside
Other NASH drugs
← Eichor home · All tracked trials · NASH studies · Weekly briefs